Metabolon Peak Science Grant Program

The Metabolon Peak Science Grant Program is a competitive quarterly grant program offered by Metabolon to advance high-impact scientific research through access to metabolomics capabilities, scientific expertise, data resources, and bioinformatics support. The program reflects Metabolon's commitment to transformative science and is intended to help researchers accelerate biological discovery through high-quality metabolomics data. Metabolon awards one Peak Science Grant each quarter. For each quarterly cycle, three finalists are selected and one winning researcher or team receives a fully funded metabolomics study. The program supports both basic and applied research and welcomes researchers in academia and industry working across disease biology, translational research, population health, microbiome research, nutrition, environmental health, and related life science disciplines. The winning project receives a Metabolon-supported metabolomics study at no cost. The award includes consultation with Metabolon scientists regarding study design and statistical power, metabolomics analysis of up to 100 qualified samples, comprehensive project deliverables including a standard interpretation report and supporting datasets, access to the Metabolon Integrated Bioinformatics Platform for data analysis and visualization, and scientific guidance for biological interpretation and downstream data analysis. A commemorative Metabolon Peak Science t-shirt is also included. No monetary award amount, total program funding amount, or cash-equivalent value for these services is stated. The source also does not identify any cost-sharing or matching requirement. The proposed project must remain feasible within the resources provided through the grant and the available sample set. The program is open to researchers seeking to use metabolomics to uncover new biology, strengthen an existing study, support translational discovery, generate preliminary data for future funding, or inform scientific decision-making. Proposed studies may include no more than 100 qualified samples. Applicants must not have a current or ongoing project with Metabolon. Metabolomics service providers, as well as projects submitted on behalf of metabolomics service providers, are not eligible for the award. Proposed projects must also be feasible within the scope of the award and the available sample set. The application form requires a sample availability date within three months of form submission. The source does not state a restriction to a particular country, U.S. state, territory, city, county, or other geographic service area. Applicants submit through the Metabolon Peak Science Grant application form. Required applicant information includes full name, email, job title, phone number, company name, industry, and country. Required study information includes project title, project purpose or objectives, experimental design with abbreviations defined and comparison groups identified, and an abstract and other study details. Applicants are asked to provide as much information as possible about the number of groups, group names, number of samples, and a short description. The application also asks whether merging data with a previous or future dataset will be required. Required sample information includes sample types, sample source such as organism or cell type, sample biosafety level and pathogen information, and the sample availability date. Submission of the form also constitutes agreement to receive information from Metabolon and agreement to its Terms of Use, Privacy Policy, and Cookie Policy. Applications are evaluated for scientific impact, feasibility, and innovation. Scientific impact considers whether a proposed study has the potential to uncover new insights, advance biological understanding, or improve scientific decision-making. Feasibility considers whether the project can reasonably be completed using the awarded resources, timeline, and available sample set. Innovation considers whether the proposed approach demonstrates creativity, originality, or a novel use of metabolomics. All applications are reviewed by a panel of senior scientific leaders from Metabolon's R&D, lab operations, and Discovery & Translational Sciences teams. The reviewers collectively bring expertise spanning diseases, research areas, biological themes, and applications. Three finalists are selected each quarter. Finalists are invited to discuss their proposed projects with a Metabolon scientific study director and business development representative. These discussions are used to confirm project feasibility, timelines, sample requirements, and other study details before the final winner is selected. Each finalist also receives a 10% credit toward a future Metabolon project. The current-quarter submission deadline is September 30, 2026, and the fourth-quarter submission deadline is December 31, 2026. Applications are reviewed promptly after each submission deadline. Because Metabolon states that one grant is awarded each quarter, the opportunity is recurring on a quarterly basis. No specific award notification date, project performance period, named individual program contact, program email address, program telephone number, or direct PDF URL is provided in the supplied source.

Emphasize scientific impact, feasibility, and innovation; show how the study can uncover new insights, advance biological understanding, or improve scientific decision-making; ensure the project can be completed with the awarded resources, timeline, and no more than 100 qualified samples; demonstrate creativity, originality, or a novel use of metabolomics; be prepared to discuss feasibility, timelines, sample requirements, and other study details if selected as a finalist.